Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC trimmed its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 22.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 467,660 shares of the company's stock after selling 133,151 shares during the period. Doximity makes up about 1.4% of Rice Hall James & Associates LLC's holdings, making the stock its 20th biggest position. Rice Hall James & Associates LLC owned approximately 0.25% of Doximity worth $24,968,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. UMB Bank n.a. grew its position in Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after buying an additional 235 shares during the last quarter. Farther Finance Advisors LLC raised its stake in shares of Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock worth $34,000 after buying an additional 603 shares during the last quarter. Morse Asset Management Inc acquired a new position in shares of Doximity during the 3rd quarter worth $46,000. Covestor Ltd raised its stake in shares of Doximity by 441.9% during the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company's stock worth $73,000 after buying an additional 1,370 shares during the last quarter. Finally, First Horizon Advisors Inc. raised its stake in shares of Doximity by 22.5% during the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company's stock worth $91,000 after buying an additional 384 shares during the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity Stock Down 3.7 %

Shares of DOCS traded down $2.75 during mid-day trading on Friday, hitting $72.25. The company had a trading volume of 3,202,946 shares, compared to its average volume of 2,419,548. The stock has a market cap of $13.49 billion, a PE ratio of 72.25, a P/E/G ratio of 4.20 and a beta of 1.39. The business's 50-day simple moving average is $60.19 and its 200-day simple moving average is $49.05. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $85.21.

Analysts Set New Price Targets

Several research analysts have recently issued reports on DOCS shares. JPMorgan Chase & Co. lifted their price target on Doximity from $30.00 to $48.00 and gave the stock a "neutral" rating in a research note on Thursday, November 21st. Wells Fargo & Company raised their price target on shares of Doximity from $43.00 to $55.00 and gave the stock an "equal weight" rating in a research note on Friday, February 7th. Barclays raised their price target on shares of Doximity from $52.00 to $75.00 and gave the stock an "overweight" rating in a research note on Monday, November 11th. Truist Financial raised their price target on shares of Doximity from $35.00 to $49.00 and gave the stock a "hold" rating in a research note on Thursday, November 14th. Finally, Canaccord Genuity Group cut shares of Doximity from a "buy" rating to a "hold" rating and raised their price target for the stock from $40.00 to $60.00 in a research note on Wednesday, November 13th. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Doximity presently has a consensus rating of "Moderate Buy" and an average price target of $64.22.

Insider Activity

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 37.40% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.